scholarly journals Single-cell entropy for accurate estimation of differentiation potency from a cell’s transcriptome

2016 ◽  
Author(s):  
Andrew E Teschendorff

AbstractThe ability to quantify differentiation potential of single cells is a task of critical importance for single-cell studies. So far however, there is no robust general molecular correlate of differentiation potential at the single cell level. Here we show that differentiation potency of a single cell can be approximated by computing the signaling promiscuity, or entropy, of a cell’s transcriptomic profile in the context of a cellular interaction network, without the need for model training or feature selection. We validate signaling entropy in over 7,000 single cell RNA-Seq profiles, representing all main differentiation stages, including time-course data. We develop a novel algorithm called Single Cell Entropy (SCENT), which correctly identifies known cell subpopulations of varying potency, enabling reconstruction of cell-lineage trajectories. By comparing bulk to single cell data, SCENT reveals that expression heterogeneity within single cell populations is regulated, pointing towards the importance of cell-cell interactions. In the context of cancer, SCENT can identify drug resistant cancer stem-cell phenotypes, including those obtained from circulating tumor cells. In summary, SCENT can directly estimate the differentiation potency and plasticity of single-cells, allowing unbiased quantification of intercellular heterogeneity, and providing a means to identify normal and cancer stem cell phenotypes.Software AvailabilitySCENT is freely available as an R-package from github: https://github.com/aet21/SCENT


Author(s):  
Melinda Fagan

I have previously argued that stem cell experiments cannot in principle demonstrate that a single cell is a stem cell ([reference omitted for anonymous review]).  Laplane and others dispute this claim, citing experiments that identify stem cells at the single-cell level.  This paper rebuts the counterexample, arguing that these alleged ‘crucial stem cell experiments’ do not measure self-renewal for a single cell, do not establish a single cell’s differentiation potential, and, if interpreted as providing results about single cells, fall into epistemic circularity.  I then examine the source of the dispute, noting differences in philosophical and experimental perspectives.



2021 ◽  
Vol 8 (8) ◽  
pp. 2004320
Author(s):  
Hua Wang ◽  
Peng Gong ◽  
Tong Chen ◽  
Shan Gao ◽  
Zhenfeng Wu ◽  
...  


2016 ◽  
Vol 35 (5) ◽  
pp. 2643-2650 ◽  
Author(s):  
YAN DING ◽  
AI QING YU ◽  
XIAO LI WANG ◽  
XING RONG GUO ◽  
YA HONG YUAN ◽  
...  


Author(s):  
Harrison Specht ◽  
Nikolai Slavov

Many pressing medical challenges - such as diagnosing disease, enhancing directed stem cell differentiation, and classifying cancers - have long been hindered by limitations in our ability to quantify proteins in single cells. Mass-spectrometry (MS) is poised to transcend these limitations by developing powerful methods to routinely quantify thousands of proteins and proteoforms across many thousands of single cells. We outline specific technological developments and ideas that can increase the sensitivity and throughput of single cell MS by orders of magnitude and usher in this new age. These advances will transform medicine and ultimately contribute to understanding biological systems on an entirely new level.



2017 ◽  
Vol 114 (28) ◽  
pp. 7283-7288 ◽  
Author(s):  
Lucas R. Blauch ◽  
Ya Gai ◽  
Jian Wei Khor ◽  
Pranidhi Sood ◽  
Wallace F. Marshall ◽  
...  

Wound repair is a key feature distinguishing living from nonliving matter. Single cells are increasingly recognized to be capable of healing wounds. The lack of reproducible, high-throughput wounding methods has hindered single-cell wound repair studies. This work describes a microfluidic guillotine for bisecting single Stentor coeruleus cells in a continuous-flow manner. Stentor is used as a model due to its robust repair capacity and the ability to perform gene knockdown in a high-throughput manner. Local cutting dynamics reveals two regimes under which cells are bisected, one at low viscous stress where cells are cut with small membrane ruptures and high viability and one at high viscous stress where cells are cut with extended membrane ruptures and decreased viability. A cutting throughput up to 64 cells per minute—more than 200 times faster than current methods—is achieved. The method allows the generation of more than 100 cells in a synchronized stage of their repair process. This capacity, combined with high-throughput gene knockdown in Stentor, enables time-course mechanistic studies impossible with current wounding methods.



2018 ◽  
Vol 16 (4) ◽  
pp. 707-719 ◽  
Author(s):  
Thu H. Truong ◽  
Hsiangyu Hu ◽  
Nuri A. Temiz ◽  
Kyla M. Hagen ◽  
Brian J. Girard ◽  
...  


2020 ◽  
Vol 117 (31) ◽  
pp. 18412-18423 ◽  
Author(s):  
Chia-Chen Hsu ◽  
Jiabao Xu ◽  
Bas Brinkhof ◽  
Hui Wang ◽  
Zhanfeng Cui ◽  
...  

Stem cells with the capability to self-renew and differentiate into multiple cell derivatives provide platforms for drug screening and promising treatment options for a wide variety of neural diseases. Nevertheless, clinical applications of stem cells have been hindered partly owing to a lack of standardized techniques to characterize cell molecular profiles noninvasively and comprehensively. Here, we demonstrate that a label-free and noninvasive single-cell Raman microspectroscopy (SCRM) platform was able to identify neural cell lineages derived from clinically relevant human induced pluripotent stem cells (hiPSCs). By analyzing the intrinsic biochemical profiles of single cells at a large scale (8,774 Raman spectra in total), iPSCs and iPSC-derived neural cells can be distinguished by their intrinsic phenotypic Raman spectra. We identified a Raman biomarker from glycogen to distinguish iPSCs from their neural derivatives, and the result was verified by the conventional glycogen detection assays. Further analysis with a machine learning classification model, utilizing t-distributed stochastic neighbor embedding (t-SNE)-enhanced ensemble stacking, clearly categorized hiPSCs in different developmental stages with 97.5% accuracy. The present study demonstrates the capability of the SCRM-based platform to monitor cell development using high content screening with a noninvasive and label-free approach. This platform as well as our identified biomarker could be extensible to other cell types and can potentially have a high impact on neural stem cell therapy.



Author(s):  
Alexander T. Pearson ◽  
Patrick Ingram ◽  
Shoumei Bai ◽  
Euisik Yoon ◽  
Trachette Jackson ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document